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ABSTRACT
The hepatitis C virus (HCV) is a significant public
health threat worldwide. The virus is highly variable
and evolves rapidly, making it an elusive target for
the immune system and for vaccine and drug
design. Presently, 50000 HCV sequences have
been published. A central website that provides
annotated sequences and analysis tools will be
helpful to HCV scientists worldwide. The HCV
sequence database collects and annotates
sequence data, and provides them to the public via
a website that contains a user-friendly search
interface and a large number of sequence analysis
tools, following the model of the highly regarded
and widely used Los Alamos HIV database. The HCV
website can be accessed via http://hcv.lanl.gov and
http://hcv-db.org.
INTRODUCTION
The hepatitis C virus (HCV) has infected 4 million people
in the United States and 170 million people worldwide.
HCV infection is cleared in 25% of cases (1,2), and in
the rest results in chronic infection. A recent study
(3) estimated that lifetime HCV-associated mortality is
around 1 in 8; a much larger number (an estimated 1 in
4) will develop cirrhosis of the liver. Most likely this
number will be higher in less developed countries.
With 170 million people infected worldwide, this means
20 million HCV-related deaths in the next few decades.
The infection has been known for decades and was
previously called non-A non-B hepatitis, but the virus was
not discovered until 1989 (4). It is spread through blood
and blood products. Reliable tests have been available
since soon after the discovery of the virus (5), but there are
still occasional outbreaks in the Western world, either
because the carrier is in the very early stage of the
infection when antibodies are not yet detectable, or by
trace amounts of virus, for example via kidney dialysis
equipment (6). Worldwide, the epidemic is still spreading
via contaminated blood and needles.
HCV is a positive-sense RNA virus with a genome of
9400 bases, which encodes a single polyprotein that is
cleaved into four structural proteins (Core, Envelope
1 and 2 and p7) and six non-structural proteins named
NS2-NS5B. It has been classiﬁed as a member of the genus
hepacivirus. Hepaciviridae in turn are part of the family
that includes Dengue, yellow fever and West Nile virus,
with which it shares many structural features. However,
the genetic distance between HCV and other ﬂaviviruses is
>50% over the entire genome (7). HCV is an extremely
variable virus that forms polymorphic swarms of variants
within the host. Worldwide, six diﬀerent genotypes have
now been deﬁned, and each of those is subdivided into a
total of more than 67 subtypes, of which 19 have been
completely sequenced.
It is expected that both the generation of escape and
resistance mutations and the high variability itself will
complicate drug and vaccine design (8). In the closely
related ﬁeld of HIV research, there is a renewed interest in
rational vaccine design, a relatively new discipline that
attempts to deﬁne the optimal vaccine strain, possibly an
artiﬁcially created one, that minimizes the diﬀerences from
circulating strains while maximizing the immunogenicity
of the reagent (9). Since for hepatitis C both drug and
vaccine design are in their infancy, a database that allows
researchers to study genetic variability by facilitating
retrieval, alignment and analysis of all publicly available
HCV sequences could play an important role in helping
these eﬀorts.
THE PURPOSE AND DESIGN OF THE DATABASE
The HCV database aims to be a resource for scientists
working on HCV genetics, evolution, variability, and
vaccine and drug design. The database is managed by
biologists with extensive experience in sequence analysis,
assisted by bioinformaticians and an editorial board
consisting of international experts in the ﬁeld of HCV
research.
The backbone of the database is formed by the HCV
sequences deposited in GenBank. New sequences are
downloaded weekly, and the available ancillary informa-
tion is extracted from the GenBank records. This
information may include country, sampling year, isolate
names, genotype and subtype, host species, etc. For most
of the sequences (excluding those shorter than 150nt),
relevant annotation information is obtained from the
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much as possible, sequences that do not have a genotype
and subtype assigned are manually typed using phyloge-
netic analysis and BLAST searches. Annotation is being
added continuously, both to newly downloaded sequences
and to sequences already in the database.
Presently, annotation ﬁelds in the database include:
Sequence information
Genotype, subtype, start and stop coordinates relative to
the reference strain HCV-H77, sampling country, -city,
-date and -tissue.
Patient information
Health status, age, gender, ALT level, treatment and
result, co-infection with HIV and hepatitis B, infection
date, -country, -city, -route, and -outcome, HLA type, and
epidemiological relations to other patients.
The information in the database can be accessed via a
versatile but user-friendly search interface that allows
searches on some 30 diﬀerent ﬁelds, and lets the user
automatically exclude sequences from non-human hosts,
sequences from patent applications and sequences that
have a close epidemiological relation (either from one
patient or from a cluster of linked infections). The search
results can be sorted and selected in various ways, and
include an icon for each sequence that shows at a glance
how long each sequence is and where in the genome it is
located. A graphical overview showing which regions and
which genotypes are included in the entire set of retrieved
sequences can be generated (Figure 1). An important
feature is the ability to search by genomic region, so the
user can locate all sequences in the database that span
(for example) E1 and E2, and include or exclude sequences
that are located in that region but do not cover it
completely. Retrieved sequences and the associated
Figure 1. Histograms showing the number, genotype and genomic region for two sets of sequences: all those sampled in Africa, and all those sampled
in the United States of America. Please note that the scales of the vertical axes are diﬀerent. It can immediately be seen that there are many
more sequences from the USA; that they are mostly of genotype 1 whereas African sequences are of all genotypes; and that the best region for
comparative analysis right now (because most background sequences would be available) in Africa would be NS5B or Core/E1, while for the US it
would be E1/E2.
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usually be codon-aligned, so that it can be translated
immediately, or as translated amino acids in any reading
frame. The retrieved background information can also be
downloaded as a tab-delimited ﬁle.
The search interface includes two other important fea-
tures. First, it allows users to automatically align their
own sequences with any database sequences that cover the
same region of the genome, and to download the resulting
alignment. Second, any alignment that has been retrieved
can be used to build a tree immediately, as sequences are
internally aligned. The tree-making module also gives the
option of adding the appropriate genotype reference
sequences to the alignment, so the sequences can be
genotyped very easily.
Some ﬁelds in the HCV database, such as the patients
HLA type, are still very lightly populated, comparing
poorly with comparable ﬁelds in the HIV database which
is maintained by the same group. This is often because
the information is not made available by the authors.
We hope that the fact that these data are now
stored centrally and made easily available will encourage
authors to provide more comprehensive information, as
has indeed happened for HIV.
TOOLS PROVIDED ON THE WEBSITE
The list here is very partial; a more elaborate review of
the possibilities of the HCV database can be found in
Ref. (10). The website provides manually optimized
HCV alignments that do not contain any closely related
sequences, as well as reference alignments, which contain
3–4 representatives of each available genotype and subtype
and can be used as background sequences in phylogenetic
trees. For all genes and proteins, a graphical overview is
presented of their overall and synonymous/nonsynon-
ymous variation (using sliding window analysis) and the
cumulative variation of each gene/protein. Also provided
is an alignment of ﬂavivirus complete genomes, along with
some results of divergence analysis of these viruses.
Figure 2 shows output from the ‘Geography tool’,
which can be used to plot frequencies of the diﬀerent
genotypes stored in the database as a function of their
geographical origin. This tool can be very useful to get a
general idea of which genotypes have been found in which
countries, as well as the density of sampling in diﬀerent
regions of the world.
Other available tools for common types of sequence
analysis, tailored to HCV sequence data, include:
‘Syn-Nonsyn’ calculates, analyzes and builds trees from
the numbers of silent (ds) and nonsilent (dn) mutations
in a codon alignment (11); ‘Glycosite’ tallies and plots
N-linked glycosylation sites (12); ‘Entropy’ plots the
variability of each portion in an alignment, and can test
diﬀerences between two alignments.
In addition, there are interfaces to several public
domain programs:
‘Treemaker’ generates Neighbor-joining trees. It
is a user-friendly interface to the DNAdist/Neighbor/
Drawtree suite from the PHYLIP package (13).
The interface works around several common problems:
it gapstrips the alignments before feeding them into
DNAdist, it preserves sequence names longer than
Figure 2. World map showing the geographical distribution of sequences with diﬀerent genotypes in the HCV database. The map was generated
using the geography tool, available on the HCV website.
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calculated distance matrix that can cause the programs to
crash. ‘BLAST’ (14) searches the HCV database for
nucleotide sequences that are most similar to the user’s
query sequence. The search can be limited to sequences
that have a valid genotype.
‘PCOORD’ (15) oﬀers a principal coordinate analysis, a
data-reduction technique similar to principal components
analysis to identify co-varying positions in groups of
sequences.
Finally, a large number of tools are made available for
manipulating or summarizing sequences. Some examples:
‘FindModel’ is a variation of Modeltest (16) a procedure
that ﬁnds the evolutionary model that is most suitable for
a given dataset and lists its parameters. ‘Gene Cutter’ is an
HCV-speciﬁc tool that ﬁnds deﬁned genes in a nucleotide
input sequence, generates the appropriate amino acid
translation, and is able to codon-align a set of sequences,
which can then be downloaded. ‘Consensus’, a versatile
tool to create consensus sequences of groups of sequences
that can be modiﬁed by a large number of parameters.
‘Branchlength’ calculates the length of the branches in
a tree between two nodes, or from a chosen node to the
endnotes below it. It can also be used to re-root and plot a
tree. ‘Sequence Locator’ is a program that ﬁnds the
coordinates of an input sequence relative to the reference
strain H77 (Figure 3). This program can be used as a
means to standardize primer and epitope numbering, and
quickly shows the user the location of an unknown HCV
sequence fragment. It provides the amino acid translation
in the correct frame if a nucleotide sequence was
submitted, and aligns the amino acid sequence against
the HCV-H77 nucleotide sequence if the input is an amino
acid sequence. Sequence locator can also be used for
reverse-complement sequences. ‘PeptGen’ is intended
to help immunologists rationally design overlapping
peptide sets to probe the immune response, taking into
account forbidden N- and C-terminal amino acids and
desired peptide length. ‘Primalign’ and ‘Epilign’ auto-
matically align a primer or epitope to the HCV complete
genome alignment. The interface returns the coordinates
(H77 numbering) and an alignment of the fragment to all
sequences in the whole genome alignment.
OTHER FUNCTIONS OF THE HCV DATABASE
The database staﬀ also tries to facilitate HCV sequence
research and analysis in other ways. For example, the
database took the initiative and secured NIH-DMID
funding to try to ﬁll the patchy record of HCV complete
genomes of all genotypes. Currently, complete genomes
are available for only 31 of the 71 oﬃcially established
geno/subtype variants. The isolation and sequencing is
being done by various groups, and the database further
supports the eﬀort by publicizing and ﬁnding potential
sample sources. The database group also supported an
initiative to standardize the HCV nomenclature (17)
and the numbering of genes and region in the HCV
genome (10).
FUTURE ENHANCEMENTS
Several new tools are close to being made public. The ﬁrst
one is a tool named Phyloplace. It will help users to both
decide which genotype and subtype their sequence
resembles, and if it is diﬀerent from all, whether it is
diﬀerent enough to be called a new subtype or even a new
genotype. Results indicate that the phylogenetic place-
ment can be done and recombinants can be detected with
reasonable accuracy (manuscript in preparation).
Recombination in HCV, while known, so far seems to
be a relatively rare phenomenon. A second tool, Distplot,
will help users calculate, analyze and generate graphs of
matrices of pairwise distances. It will take a sequence
alignment and (when applicable) grouping information,
calculate various distance measures, provide summary
statistics and signiﬁcance tests and plot the distances
relative to each other or to one sequence or group (e.g. the
ﬁrst sample in a time series).
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